Category: Sponsors

Canada House is Pleased to Announce Its Joint Venture With Nutritional High, an Expert in Cannabis Oil Extracts and Edibles

TORONTO, Oct. 17, 2017 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc.’s (“Canada House“) (CSE:CHV) wholly owned subsidiary Abba Medix Corp. (“Abba”) and Nutritional High International Inc. (“Nutritional High“) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) have entered into a letter of intent (“LOI“) to create a joint venture (“Joint Venture”) to manufacture cannabis oil extracts and cannabis-infused products in Canada under the Access to Cannabis for Medical Purposes Regulations (Canada) (“ACMPR“). Abba, a subsidiary of Canada House, and Nutritional High have agreed to form a Joint Venture company which will initially focus on building out an approximate 2,000 square foot area at Abba’s Pickering cannabis grow facility, to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR. As the Health Canada regulations continue to evolve, the Joint Venture will introduce additional products, all produced in accordance with Good Pharmacoepidemiology Practice guidelines so it can sell internationally. Abba and Nutritional High expect the Joint Venture to open up new avenues of enterprise for both companies combining Canada House’s Canadian Licensing, its ability to supply trim and shake at a low cost, and introducing its burgeoning patient base to Nutritional High’s proven ability to extract top quality, high potency cannabis oil on a cost competitive basis. Larry Bortles, Chairman of Canada House commented: “The Joint Venture provides us with an opportunity to partner with experts in...

Read More

Friday Night Inc. Provides Update on AMA Expansion

VANCOUVER, B.C., CANADA (16 Oct 2017) – Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) is pleased to provide a progress update on the Nevada expansion and construction process for its subsidiary, Alternative Medicine Association (AMA). AMA has received the approval of the Nevada Clark County’s Sunrise Manor Town Advisory Board on its proposed construction of a commercial building for cannabis cultivation under the Planning and Zoning Design Review. This planning and zoning matter approved at this meeting is now forwarded to the Board of County Commissioners (BCC) for final action at their November 8th, 2017 meeting. This specific milestone shows a positive and welcoming acceptance at the local level to AMA’s building expansion for its new cultivation center. The final step in the Land Use Application for this site will be the scheduled item on the November 8th agenda. Mark Zobrist, Manager of AMA, stated, “Once we obtain the County Commissioners approval on November 8th, we will finalize the land purchase and anticipate beginning actual construction by mid-November. This is a significant advancement of this project.” In addition to the above, Alternative Medicine Association has submitted and received the necessary building permits to begin construction once the final approvals are in place. John Goss, President, stated “By transferring the old building permit number, we have effectively shortened the start up time by at least 3...

Read More

Cannabis Legislation – HR 3530 Introduced

SHARE THIS POST July 31, 2017 – Representative James Comer (R-KY) has introduced H.R. 3530: To amend the Controlled Substances Act to exclude industrial hemp from the definition of marijuana, and for other purposes. The proposed legislation has 15 cosponsors, including Garland Barr (R-KY), Earl Blumenauer (D-OR), Suzanne Bonamici (D-OR), Steve Cohen (D-TN), Kevin Cramer (R-ND), Peter DeFazio (D-OR), Tulsi Gabbard (D-HI), Bob Goodlatte (R-VA), Morgan Griffith (R-VA), Thomas Massie (R-KY), Ed Pearlmutter (D-CO), Collin Peterson (D-MN), Jared Polis (D-CO), Kurt Schrader (D-OR) and Don Young (R-AK). The bill is assigned to the House Energy and Commerce, and the House Judiciary committees. TroyFlowers Author description...

Read More

Cannabis Legislation – HR 3534 Introduced

SHARE THIS POST July 31, 2017 – Representative Suzan DelBene (D-WA) has introduced H.R. 3534: To make the Controlled Substances Act inapplicable with respect to marijuana in states that have legalized marijuana and have in effect a statewide regulatory regime to protect certain Federal interests, and for other purposes. The proposed legislation has three cosponsors, David Cicilline (D-RI), Steve Cohen (D-TN) and Adam Smith (D-WA), and is assigned to the House Energy and Commerce, as well as the House Judiciary committees. TroyFlowers Author description...

Read More

Organigram Reports Q3 Financial Results – Increased Product Quality – 25% Patient Growth

SHARE THIS POST MONCTON, NEW BRUNSWICK–(Marketwired – July 28, 2017) – Organigram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (“Organigram” or the “Company“) announces the financial results for the quarter ending May 31, 2017. Organigram’s financial results for the quarter completed May 31, 2017 included expenses associated with the implementation of an industry leading quality assurance program (the “QA Program“). The QA Program was implemented to ensure that the Company produces the highest quality product available in the marketplace and in response to a previously announced voluntary recall of certain product produced in 2016. As a result of Organigram’s increased focus on product quality and safety with the stated objective of establishing a leadership position in such regard within the industry, the Company focused on introducing product of the highest quality to the market. In practice, the program effectively identified product lots that were to be removed from inventory well before being introduced to the marketplace. The successful implementation of this program resulted in a reduction in inventory value for the quarter. Organigram is pleased with the results and progress made during the quarter from an operational perspective and management is confident that these actions build the foundation for long-term success for the Company. This focus on product quality contributed to a 25% net increase in registered patients in Q3 when compared to Q2. Additionally, the Company continued to make significant headway...

Read More